Clinical Advisory Board to Provide Strategy for Advancing Preclinical Oncology Program in Mesothelioma AUSTIN, Texas, Sept. 19, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing...
Genprex Announces Formation of Mesothelioma Clinical Advisory Board
Seaking AlphaSeeking Alpha / Seaking Alpha 19 hours ago 1 Views
Comments